Re: 'Is a randomized trial of a short course of aminoglycoside added to ß-lactam antibiotics for empirical treatment in critically ill patients with sepsis justified?' Pharmacokinetic/pharmacodynamic considerations.

Heffernan, A; Lipman, J; Roberts, J

Heffernan, A; Lipman, J; Roberts, J.

Afiliação

Heffernan A; School of Medicine, Griffith University, Gold Coast, Qld, Australia; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, University of Queensland, Brisbane, Qld, Australia.
Lipman J; University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Qld, Australia; Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia.
Roberts J; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Qld, Australia; Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia. Electronic address: j.roberts2@uq.edu.au.

Clin Microbiol Infect ; 24(6): 666-667, 2018 06.

Article em En | MEDLINE | ID: mdl-29309932

Assuntos

Aminoglicosídeos; Estado Terminal; Antibacterianos; Humanos; Sepse; beta-Lactamas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Terminal / Aminoglicosídeos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Microbiol Infect Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google